Trial · NCT01335009
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Progression-free Survival (PFS) at Week 24 | MORAb-004 2 mg/kg | 13.5 | 95% Confidence Interval 5.0 to 26.4 | percentage of participants | |
| Percentage of Participants With Progression-free Survival (PFS) at Week 24 | MORAb-004 4 mg/kg | 8.9 | 95% Confidence Interval 2.3 to 21.3 | percentage of participants | |
| Percentage of Participants With PFS at Weeks 16 and 52 | MORAb-004 2 mg/kg | Week 16 | 32.5 | 95% Confidence Interval 18.3 to 47.6 | percentage of participants |
| Percentage of Participants With PFS at Weeks 16 and 52 | MORAb-004 4 mg/kg | Week 16 | 20.8 | 95% Confidence Interval 9.2 to 35.7 | percentage of participants |
| Percentage of Participants With PFS at Weeks 16 and 52 | MORAb-004 2 mg/kg | Week 52 | NA | 95% Confidence Interval NA to NA | percentage of participants |
| Percentage of Participants With PFS at Weeks 16 and 52 | MORAb-004 4 mg/kg | Week 52 | 8.9 | 95% Confidence Interval 2.3 to 21.3 | percentage of participants |
| Overall Survival (OS) | MORAb-004 2 mg/kg | 40.9 | 95% Confidence Interval 29.0 to 53.3 | weeks | |
| Overall Survival (OS) | MORAb-004 4 mg/kg | 29.3 | 95% Confidence Interval 22.9 to 35.4 | weeks | |
| Percentage of Participants With Overall Response | MORAb-004 2 mg/kg | NA | 95% Confidence Interval NA to NA | percentage of participants | |
| Percentage of Participants With Overall Response | MORAb-004 4 mg/kg | 3.1 | 95% Confidence Interval 0.0 to 9.2 | percentage of participants | |
| Optimal Biologic Dosing (OBD) of Morab-004 | MORAb-004 2 mg/kg | NA | milligram(s) | ||
| Optimal Biologic Dosing (OBD) of Morab-004 | MORAb-004 4 mg/kg | NA | milligram(s) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01335009/results